65,437 trials
Cartilage or Osteochondral Defects in the Knee · Up to Moderate Osteoarthritis
Primary: Overall Knee Injury and Osteoarthritis Outcome Score (KOOS) Change From Baseline to 60 Months — 38.75; 19.52 score on a scale
Healthy
Primary: Part 1: Area Under the Plasma Concentration-Time Curve From Time Zero Extrapolated to Infinity (AUC0-inf) of Digoxin — 15.8; 18.7 Hour*nanogram per milliliter (h*ng/mL)
Brain Neoplasm · Recurrent Brain Neoplasm
Primary: Intervention Compliance — 0.39; 0.50 Proportion of Participants
Acute Lymphocytic Leukemia
Primary: The Incidence of Adverse Drug Reactions — 72; 21 Participants
Basic Science
Primary: Motor Skill — 66.6; 59.4; 59.9; 64.9 Accuracy (%) — p=0.55
Influenza · COVID-19
Primary: Cohort 1: Percentage of Participants With Any Local Reactions for up to 7 Days Following Vaccination in Investigational Vaccine Extremity — 74.7; 59.1 Percentage of…
Covid19
Primary: Assessment of Seroconversion, Defined as Development of Immunoglobulin G (IgG) Antibodies Against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) After…
Depressive Symptoms
Primary: Percentage of Eligible Participants Who Agreed to Participate in the Trial — 120 Participants
Gestational Diabetes
Primary: Number of Neonates That Show Composite Adverse Neonatal Outcome — 130; 114 Participants
Atrial Fibrillation
Primary: Percentage of Ablated Left Atrial Posterior Wall With a 31 mm Balloon Size POLARx FIT — 35.4 percentage of posterior wall
Respiratory Distress Syndrome, Adult
Primary: Change in Oxygenation Index (OI) — -0.7; -1.5; 0.8; -1.1 cmH20/mmHg — p=0.34
Oxygenation · Manual Ventilation · Mechanical Ventilation
Primary: The % Change in Mean Artery Blood Pressure — -3.73; 13 % change in mean artery pressure
Non Small Cell Lung Cancer
Primary: Efficacy of Atezolizumab in Combination With Bevacizumab - PFS — 11.3 Months
Anesthesia
Primary: Insertion Depth at Initial Sensory Detection — 7.75; 4.65; 0.4; 8.55 mm
Cardiac Amyloidosis
Primary: Rate of Cardiac Amyloidosis Diagnosis — 24 Participants